Abstract:As the long non-coding RNAs (lncRNAs) play important roles during the incurrence and development of various human diseases, identifying disease-related lncRNAs can contribute to clarifying the pathogenesis of diseases. Most of the recent lncRNA-disease association prediction methods utilized the multi-source data about the lncRNAs and diseases. A single lncRNA may participate in multiple disease processes, and multiple lncRNAs usually are involved in the same disease process synergistically. However, the previous methods did not completely exploit the biological characteristics to construct the informative prediction models. We construct a prediction model based on adaptive hypergraph and gated convolution for lncRNA-disease association prediction (AGLDA), to embed and encode the biological characteristics about lncRNA-disease associations, the topological features from the entire heterogeneous graph perspective, and the gated enhanced pairwise features. First, the strategy for constructing hyperedges is designed to reflect the biological characteristic that multiple lncRNAs are involved in multiple disease processes. Furthermore, each hyperedge has its own biological perspective, and multiple hyperedges are beneficial for revealing the diverse relationships among multiple lncRNAs and diseases. Second, we encode the biological features of each lncRNA (disease) node using a strategy based on dynamic hypergraph convolutional networks. The strategy may adaptively learn the features of the hyperedges and formulate the dynamically evolved hypergraph topological structure. Third, a group convolutional network is established to integrate the entire heterogeneous topological structure and multiple types of node attributes within an lncRNA-disease-miRNA graph. Finally, a gated convolutional strategy is proposed to enhance the informative features of the lncRNA-disease node pairs. The comparison experiments indicate that AGLDA outperforms seven advanced prediction methods. The ablation studies confirm the effectiveness of major innovations, and the case studies validate AGLDA's ability in application for discovering potential disease-related lncRNA candidates.

HGNNLDA: Predicting Lncrna-Drug Sensitivity Associations Via a Dual Channel Hypergraph Neural Network

Predict lncRNA-drug associations based on graph neural network

Identification of associations between lncRNA and drug resistance based on deep learning and attention mechanism

Dual-Channel Heterogeneous Graph Neural Network for Predicting Microrna-Mediated Drug Sensitivity.

Attention-based Cross Domain Graph Neural Network for Prediction of Drug-Drug Interactions.

Heterogeneous graph neural network for lncRNA-disease association prediction

Predicting Associations between circRNAs and Drug Sensitivity using Heterogeneous Graphs and Graph Attention Networks.

Predicting Circrna-Drug Sensitivity Associations by Learning Multimodal Networks Using Graph Auto-Encoders and Attention Mechanism.

HGCLMDA: Predicting mRNA-Drug Sensitivity Associations via Hypergraph Contrastive Learning

Heterogeneous network and graph attention auto-encoder for LncRNA-disease association prediction

LRGCPND: Predicting Associations between ncRNA and Drug Resistance via Linear Residual Graph Convolution

LncRNA-disease association prediction method based on heterogeneous information completion and convolutional neural network

Learning Association Characteristics by Dynamic Hypergraph and Gated Convolution Enhanced Pairwise Attributes for Prediction of Disease-Related lncRNAs

Predicting Potential Drug-Disease Associations Based on Hypergraph Learning with Subgraph Matching

Graph Neural Network with Self-Supervised Learning for Noncoding RNA-Drug Resistance Association Prediction

Prediction of lncRNA–Disease Associations via Closest Node Weight Graphs of the Spatial Neighborhood Based on the Edge Attention Graph Convolutional Network

DeepWalk-aware Graph Attention Networks with CNN for Circrna-Drug Sensitivity Association Identification.

Exploring Ncrna-Drug Sensitivity Associations Via Graph Contrastive Learning

GEnDDn: An lncRNA–Disease Association Identification Framework Based on Dual-Net Neural Architecture and Deep Neural Network

gGATLDA: lncRNA-disease association prediction based on graph-level graph attention network

MNCLCDA: Predicting Circrna-Drug Sensitivity Associations by Using Mixed Neighbourhood Information and Contrastive Learning